Search - tctmd.com

Displaying 1 - 20 of 256

Sort: Relevancy | Date

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Daily News

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

Caitlin E. Cox

March 06, 2026

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Todd Neale

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Presenter: Makiko Nakamura

March 04, 2026

Presentation THT 2026

Intraluminal Outflow Graft Thrombus of Left Ventricular Assist Device: A Case Study

Presenter: Kinjal Banerjee

March 04, 2026

Presentation THT 2026

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Presenter: David Israeli

March 03, 2026

Presentation THT 2026

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Presenter: Toluwalase Awoyemi

March 03, 2026

Presentation THT Abstracts 2026

Determinants of Peak Cardiac Output and Filling Pressures During Maximal Exercise in HeartMate3 Left Ventricular Assist Device: Insights from Invasive Hemodynamics and Cardiovascular Modeling

Presenter: David Golombeck

March 02, 2026

Presentation THT 2026

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

Presenter: Andre Simon

March 02, 2026

Presentation THT 2026

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Presenter: Jonathan Grinstein

March 02, 2026

Presentation THT 2026

Development and Validation of a Model to Predict Risk of Dialysis Following Ventricular Assist Device Placement

Presenter: Wendy McCallum

March 02, 2026

Presentation THT 2026

Left Ventricular Assist Devices And Cachexia: Improved Outcomes With Nutritional Consult Intervention

Presenter: Manthan Patel

March 02, 2026

Presentation THT 2026

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Presenter: Thomas Cascino

March 02, 2026

Presentation THT 2026

Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series

Presenter: Vaidehi Mendpara

March 02, 2026

Presentation THT 2026

Characteristics and Long-Term Outcomes of Left Ventricular Assist Device Patients with an Implanted Pulmonary Artery Pressure Sensor: Insights from the Hemodynamic Frontiers in Heart Failure (HF2) Registry

Presenter: Elizabeth Volz

March 02, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

News Daily News

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

Caitlin E. Cox

January 15, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

Advertisement

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Intraluminal Outflow Graft Thrombus of Left Ventricular Assist Device: A Case Study

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Determinants of Peak Cardiac Output and Filling Pressures During Maximal Exercise in HeartMate3 Left Ventricular Assist Device: Insights from Invasive Hemodynamics and Cardiovascular Modeling

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Development and Validation of a Model to Predict Risk of Dialysis Following Ventricular Assist Device Placement

Left Ventricular Assist Devices And Cachexia: Improved Outcomes With Nutritional Consult Intervention

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series

Characteristics and Long-Term Outcomes of Left Ventricular Assist Device Patients with an Implanted Pulmonary Artery Pressure Sensor: Insights from the Hemodynamic Frontiers in Heart Failure (HF2) Registry

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

THT 2026: What to Expect in Boston

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content